A DPP-IV inhibitor, used to inhibit the enzymatic activity of DPP-IV, can be used to treat T2DM to maintain the activity of incretins so that a decrease in the blood-glucose level is stimulated. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.